Idorsia Ltd (OTCMKTS:IDRSF) Short Interest Down 15.5% in September

Idorsia Ltd (OTCMKTS:IDRSF) was the recipient of a large drop in short interest in the month of September. As of September 15th, there was short interest totalling 4,645,200 shares, a drop of 15.5% from the August 31st total of 5,498,400 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

Idorsia Price Performance

IDRSF stock remained flat at $2.59 during mid-day trading on Monday. The stock has a fifty day moving average of $2.50 and a 200-day moving average of $2.40. Idorsia has a 52-week low of $1.40 and a 52-week high of $5.56.

About Idorsia

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.